Phlebolymphedema: Health and Economic Benefits of Flexitouch Therapy
This insurance-claims analysis, published in the Journal of Vascular Surgery, reveals the impact of Flexitouch therapy on healthcare costs in venous-related lymphedema (phlebolymphedema).
Flexitouch therapy plus conservative treatment reduced healthcare costs by:
- 69% compared with conservative therapy alone.
- 85% compared with simple pneumatic compression devices (SPCDs).
- 53% compared with other advanced pneumatic compression devices (APCDs).